Merus (MRUS) Revenue & Revenue Breakdown
Merus Revenue Highlights
Latest Revenue (Y)
$43.95M
Latest Revenue (Q)
$7.33M
Main Segment (Y)
Collaboration Revenue
Merus Revenue by Period
Merus Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $43.95M | 5.68% |
| 2022-12-31 | $41.59M | -15.32% |
| 2021-12-31 | $49.11M | 64.00% |
| 2020-12-31 | $29.94M | -3.82% |
| 2019-12-31 | $31.13M | -13.46% |
| 2018-12-31 | $35.97M | 141.72% |
| 2017-12-31 | $14.88M | 420.44% |
| 2016-12-31 | $2.86M | 98.90% |
| 2015-12-31 | $1.44M | 52.16% |
| 2014-12-31 | $944.84K | 262.03% |
| 2013-12-31 | $260.98K | - |
Merus generated $43.95M in revenue during NA 2023, up 5.68% compared to the previous quarter, and up 122.17% compared to the same period a year ago.
Merus Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $7.33M | -7.06% |
| 2024-03-31 | $7.89M | -11.75% |
| 2023-12-31 | $8.94M | -18.98% |
| 2023-09-30 | $11.03M | 5.32% |
| 2023-06-30 | $10.48M | -22.39% |
| 2023-03-31 | $13.50M | 26.56% |
| 2022-12-31 | $10.67M | 62.07% |
| 2022-09-30 | $6.58M | -48.12% |
| 2022-06-30 | $12.68M | 8.83% |
| 2022-03-31 | $11.65M | -20.76% |
| 2021-12-31 | $14.71M | 7.61% |
| 2021-09-30 | $13.67M | 10.42% |
| 2021-06-30 | $12.38M | 48.25% |
| 2021-03-31 | $8.35M | -7.39% |
| 2020-12-31 | $9.02M | 5.20% |
| 2020-09-30 | $8.57M | 41.51% |
| 2020-06-30 | $6.06M | -3.89% |
| 2020-03-31 | $6.30M | -18.47% |
| 2019-12-31 | $7.73M | -13.84% |
| 2019-09-30 | $8.97M | 38.69% |
| 2019-06-30 | $6.47M | -25.23% |
| 2019-03-31 | $8.65M | -10.73% |
| 2018-12-31 | $9.69M | 28.28% |
| 2018-09-30 | $7.55M | 1.61% |
| 2018-06-30 | $7.43M | -38.81% |
| 2018-03-31 | $12.15M | 165.35% |
| 2017-12-31 | $4.58M | 13.08% |
| 2017-09-30 | $4.05M | 9.77% |
| 2017-06-30 | $3.69M | 52.98% |
| 2017-03-31 | $2.41M | 105.59% |
| 2016-12-31 | $1.17M | 17.18% |
| 2016-09-30 | $1.00M | 368.57% |
| 2016-06-30 | $213.57K | 236.51% |
| 2016-03-31 | $63.47K | 201.29% |
| 2015-12-31 | $21.06K | -80.70% |
| 2015-09-30 | $109.14K | -91.20% |
| 2015-06-30 | $1.24M | 1945.55% |
| 2015-03-31 | $60.64K | -87.31% |
| 2014-12-31 | $477.88K | 20.26% |
| 2014-09-30 | $397.38K | - |
Merus generated $7.33M in revenue during Q2 2024, up -7.06% compared to the previous quarter, and up 54.32% compared to the same period a year ago.
Merus Revenue Breakdown
Merus Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Collaboration Revenue | $43.95M | $41.59M | $19.50M | $3.36M | $5.52M |
| Collaboration Revenue Related Party | - | - | $29.60M | $26.58M | $25.83M |
| Grant Revenue | - | - | - | - | $-215.00K |
Merus's latest annual revenue breakdown by segment (product or service), as of Dec 23: Collaboration Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Collaboration Revenue | $7.33M | $7.89M | $8.94M | $11.03M | $10.48M | $13.50M | $10.67M | $6.58M | $12.68M | $11.65M | $6.87M | $5.92M | $5.12M | $1.60M | $2.16M | $695.00K | $184.00K | $328.00K | - |
| Collaboration Revenue Related Party | - | - | - | - | - | - | - | - | - | $7.84M | $7.75M | $7.26M | $6.75M | $6.86M | $7.88M | $5.87M | $5.97M | - | - |
| Upfront and Milestone Payments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $200.00K |
Merus's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Collaboration Revenue (100.00%).
Merus Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STRO | Sutro Biopharma | $153.73M | $13.01M |
| PTGX | Protagonist Therapeutics | $60.00M | $4.17M |
| MRUS | Merus | $43.95M | $7.33M |
| ADAG | Adagene | $18.11M | $833.34K |
| ANAB | AnaptysBio | $17.16M | $10.97M |
| KRON | Kronos Bio | $6.29M | $2.69M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| INBX | Inhibrx | $1.80M | - |
| LYEL | Lyell Immunopharma | $130.00K | $3.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| PCVX | Vaxcyte | - | - |
| CERE | Cerevel Therapeutics | - | - |
| REPL | Replimune Group | - | - |
| KURA | Kura Oncology | - | - |
| SNDX | Syndax Pharmaceuticals | - | $3.50M |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
MRUS Revenue FAQ
What is Merus’s yearly revenue?
Merus's yearly revenue for 2023 was $43.95M, representing an increase of 5.68% compared to 2022. The company's yearly revenue for 2022 was $41.59M, representing a decrease of -15.32% compared to 2021. MRUS's yearly revenue for 2021 was $49.11M, representing an increase of 64.00% compared to 2020.
What is Merus’s quarterly revenue?
Merus's quarterly revenue for Q2 2024 was $7.33M, a -7.06% decrease from the previous quarter (Q1 2024), and a -30.01% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.89M, a -11.75% decrease from the previous quarter (Q4 2023), and a -41.56% decrease year-over-year (Q1 2023). MRUS's quarterly revenue for Q4 2023 was $8.94M, a -18.98% decrease from the previous quarter (Q3 2023), and a -16.19% decrease year-over-year (Q4 2022).
What is Merus’s revenue growth rate?
Merus's revenue growth rate for the last 3 years (2021-2023) was -10.51%, and for the last 5 years (2019-2023) was 41.16%.
What are Merus’s revenue streams?
Merus's revenue streams in c 23 are Collaboration Revenue
What is Merus’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Merus was Collaboration Revenue. This segment made a revenue of $43.95M, representing 100.00% of the company's total revenue.